Background: As nuclear receptors and transcription factors have an important regulatory function in adipocyte differentiation and fat storage, genetic variation in these key regulators and downstream pathways may be involved in the onset of obesity. Objective: To explore associations between single nucleotide polymorphisms (SNPs) in candidate genes from regulatory pathways that control fatty acid and glucose metabolism, and repeated measurements of body mass index (BMI) and waist circumference in a large Dutch study population. Methods: Data of 327 SNPs across 239 genes were analyzed for 3575 participants of the Doetinchem cohort, who were examined three times during 11 years, using the Illumina Golden Gate assay. Adjusted random coefficient models were used to analyze the relationship between SNPS and obesity phenotypes. False discovery rate q-values were calculated to account for multiple testing. Significance of the associations was defined as a q-value p0.20. Results: Two SNPs (in NR1H4 and SMARCA2 in women only) were significantly associated with both BMI and waist circumference. In addition, two SNPs (in SIRT1 and SCAP in women only) were associated with BMI alone. A functional SNP, in IL6, was strongly associated with waist. Conclusion: In this explorative study among participants of a large population-based cohort, five SNPs, mainly located in transcription mediator genes, were strongly associated with obesity phenotypes. The results from whole genome and candidate gene studies support the potential role of NR1H4, SIRT1, SMARCA2 and IL6 in obesity. Although replication of our findings and further research on the functionality of these SNPs and underlying mechanism is necessary, our data indirectly suggest a role of GATA transcription factors in weight control.
Introduction
Overweight and obesity are defined by WHO as an excessive accumulation of body fat.
1 Worldwide, about 1.6 billion people are overweight (body mass index: BMIX25 kg/m 2 ), of which about 400 million suffer from obesity (BMIX30 kg/m 2 ). 2 Consequences of the obesity epidemic are an increase in the occurrence of cardiovascular diseases, diabetes, musculoskeletal disorders, such as osteoarthritis of knee and hip, and certain types of cancers. 3, 4 Cardiovascular diseases are the main cause of death worldwide and diabetes has rapidly grown into a global epidemic. 5 Therefore, overweight is a serious threat to public health. BMI is the most frequently used measure to define overweight and obesity at the population level. 6 At similar BMI levels, however, the amount of abdominal fat and associated health risk can differ significantly. A more sensitive measure is waist circumference, which gives information about the central fat distribution and is used to define abdominal obesity.
Although environmental factors have an important function, there is significant evidence for a heritable component in obesity. 8, 9 In general, the total variance in BMI explained by genetic factors varies between 20 and 90%, with a most probable value around 40%. 10, 11 For waist, the heritability estimates range from 40 to 80%. 6 The 2005 update of the human obesity gene map reported 426 associations between candidate genes and obesity phenotypes. 8 Despite the long list of positive findings, meta-analyses showed sufficient evidence for an association with BMI or obesity for five genes only (PPARY2, FTO, MC4R, TNFa, PCSK1). [12] [13] [14] [15] [16] The inconsistencies among individual studies can partly be explained by a lack of power to replicate the typically moderate-to-small effects of a single locus on polygenic obesity. 6, 17 Currently, a limited number of cohort studies evaluated associations between genetic variation in candidate genes and waist. [18] [19] [20] In the last decade, it became feasible and affordable to analyze a large number of single nucleotide polymorphisms (SNPs) simultaneously. Genome-wide association studies, a hypothesis-free approach to find genetic areas associated with a trait, identified associations between genetic variations in the INSIG2, FTO, CTNNBL1 and MC4R gene and obesity. 15, [21] [22] [23] So far, very few studies used a hypothesisdriven pathway-based approach to study many genes from the same pathway in relation to obesity. 24 Nuclear receptors are transcription factors that regulate the expression of target genes through binding to a specific DNA sequence in the target gene, the so-called hormone response element. Genetic variation in a DNA-binding domain of the nuclear receptor or the target gene, in the genes coding for their co-activators, co-repressors and other involved proteins, may lead to differential expression of the target genes. The nuclear receptors PPAR, LXR and FXR (encoded by NR1H4), the SREBP transcription factors and the insulin receptor have an important regulatory function in adipocyte differentiation, fatty acid synthesis, fatty acid oxidation, fat storage in adipose tissue and glucose homeostasis. 25 Therefore, genetic variation in these key regulators and their pathways may be involved in the onset of obesity. The aim of this study was to explore the associations between a large number of SNPs across candidate genes from regulatory pathways that control fatty acid and glucose metabolism, and repeated measurements of BMI and waist circumference in a representative and large population-based Dutch cohort (n ¼ 3575).
Materials and methods

Study population
The Doetinchem Study is a cohort study on lifestyle, biological risk factors and chronic diseases. 26 Inhabitants of Doetinchem, a town in a rural area in the east of the Netherlands, were invited to take part in the study. Between 1987 and 1991, random samples were taken from the municipal population register. A total of 12 404 inhabitants aged 20-59 years were willing to participate and underwent a first measurement (response 62%). A subsample of the baseline cohort (63%) was re-invited for a second measurement between 1993 and 1997. A total of 6100 participants were re-examined (response 79%). Between 1998 and 2002, a third measurement took place and 4917 participants were reassessed (response 75%). In total, 4662 persons had three repeated measurements. All participants gave written informed consent and approval was obtained from local Medical-Ethical Committees. Pregnancy and alteration in smoking behavior are factors that influence body weight. Therefore, participants of the Doetinchem Cohort who changed their smoking habits (n ¼ 750), who had missing data on smoking status (n ¼ 11) or who were pregnant at the time of measurement (n ¼ 122) were excluded. Finally, 3779 participants met the inclusion criteria of this study.
Measures
Information about demographic characteristics, pregnancy and lifestyle factors, including smoking status, were collected at each measurement round using standardized questionnaires. Smoking status was defined as non-smoking (i.e. smoking less than one cigarette per month), smoking and ex-smoking. Anthropometric data were collected by four trained research assistants in a similar manner at each visit to the municipal health center. The research assistants were audited once a year on compliance to protocol procedures. All measurements were performed on subjects wearing light indoor clothing with emptied pockets and without shoes. Body weight (kg) was measured to the nearest 0.5 kg and height (cm) to the nearest 0.5 cm. To adjust for light indoor clothing, 1 kg was subtracted from the measured body weight. BMI was calculated as weight (kg) divided by the square of height (m). Overweight and obesity were defined as, respectively, a BMI X25 and 30 kg/m 2 . At the second and third visit, waist circumference was measured according to written instructions based on WHO criteria for waist measurement (1989). 27 Waist circumference was determined to the nearest 0.5 cm, at midway between the lowest rib and the iliac crest, with subjects in standing position and after breathing out gently. Waist circumference was measured in duplicate and the mean of the two measurements was taken.
Abdominal obesity was defined as a waist circumference X88 cm for women and X102 cm for men. Non-fasting blood samples were taken from all participants, which were fractionated into blood serum, buffy coat and erythrocytes and subsequently stored at À30 1C until further use. DNA was extracted using a salting out method as described by Hoebee et al.
28
Selection of candidate genes and SNPs Candidate genes were selected by a pathway-driven approach based on literature, with emphasis on regulatory pathways that control fatty acid, glucose, cholesterol and bile salt homeostasis. 25 The selection procedure started from the master regulator genes encoding nuclear receptors (PPARs, LXR, FXR (NR1H4)) and transcription factors (SREBPs) and continued by selecting their co-activators, corepressors and target genes. In addition, hormonal receptors (insulin receptor) and their downstream signaling proteins were selected. Furthermore, several candidate genes, described in literature, to be associated with blood lipids or blood pressure, were added. The selection resulted in 251 candidate genes. When available, eligible SNPs for these genes were selected based on published associations with any disorder or functional parameter, using databases NCBI (Pubmed, Gene and SNP), Genetic Association Database, 29 CDC and SNPper. 30 Subsequently, we used the web-based program SNPselector 31 to query all the genes for potential candidate SNPs. The default ranking settings of the performed 'SNPs by gene' search, including 5 kb 5 0 and 1 kb 3 0 flanking sequence, were slightly modified. First, SNPs located in repeat regions were excluded (Repeat_score40), to avoid potential genotyping difficulties. Second, Caucasian minor allele frequencies (MAFs) higher than 0 had to be available (MAF_Caucasian40). Third, SNPs in predicted transcription factor-binding sites (TFBS) were preferred (Regulatory ¼ *TFBS*). Finally, subsequent ranking was based on the highest function score (Function_score), followed by the highest regulatory score (Regulatory_score), discriminating between SNPs that might affect gene transcript structure or protein product, and the regulatory potential of the SNP, respectively.
For the majority of the genes, one or two SNPs that were most likely to be functional based on observed associations or the criteria from SNP selector were selected. For only a few genes, mainly the master regulator genes, which served as a starting point in our pathway approach, up to seven SNPs were selected. MAF of the selected SNPs in Caucasians had to be larger than or near to 5% based on available information (literature and Hapmap). Four of the 253 selected candidate genes remained without eligible SNPs in the SNP search described above. For each of these genes (SCAP, ACSL1, CEBPA, E2F4), a single SNP was handpicked based on Caucasian allele frequency, SNP location and validation information in NCBI SNP. In part limited by various constrains of the Golden Gate genotyping assay, our final SNP set consisted of 384 SNPs across 251 candidate genes, including one Y chromosome marker to serve as a gender control (see Supplementary table) . A total of 153 SNPs across 91 genes were selected by literature and 226 SNPs across 178 genes were selected by SNPselector. Type 2 Failure_Codes (SNP in duplicated/repetitive region) of the Illumina Assay Design Tool were ignored when occurring in Golden Gate validated SNPs (SNP_Score ¼ 1.1). All SNP_Scores were 40.4.
Gene subclassification
Genes that exercise transcriptional control of lipid and glucose metabolism were termed as transcription mediators, whereas their targets and signal transducers were termed as effectors. When both classifications were applicable; for example, several nuclear receptors and co-activators exert transcriptional control over one another, classification preference was given toward transcription mediator.
Genotyping
A total of 139 subjects were not eligible for genotyping, mainly because of failure to extract DNA or because buffy coats were not available. For 3640 subjects, high throughput SNP genotyping was performed with the Illumina Golden Gate assay using the Sentrix Array Matrix platform (Illumina Inc, San Diego, CA, USA). 32 Illumina GenCall software, (version 6.1.3.28) was used for automated genotype clustering and calling. Two independent researchers each visually inspected all cluster plots to validate and/or correct the automated genotype calling. Genotyping failed for 43 subjects because of an overall absence of any signal. In addition, 22 subjects were excluded: 21 because of discordance for the gender control and 1 male subject because of heterozygous genotyping of several SNPs on the X chromosome. For 28 SNPs, the genotype calling did not succeed because of low signal (n ¼ 11) overlap between the genotype clusters (n ¼ 13), multiple genotype clusters (n ¼ 3) or scattering of clusters (n ¼ 1). Furthermore, genotype calling was not completely convincing for 42 SNPs. Finally, for 3575 participants (1710 men and 1865 women), genotype data was available.
Quality control
To examine the credibility of the genotyping data, a subsample of SNPs for which genotype calling was not completely convincing (n ¼ 10; 24%) was verified in a random sample (n ¼ 96), using Taqman or Pyrosequencing.
As verification showed no disagreement with the original results, genotyping of the remaining 32 SNPs was only verified when an association with BMI or waist was found for the particular SNP and all 42 SNPs were included in the analysis.
In addition, 33 SNPs were not in Hardy Weinberg equilibrium (HWE), of which three still deviated from HWE after adjustment for multiple testing (qo0.05; see statistical analysis). Verification was carried out on a random sample (n ¼ 96) for the eight SNPs (24%) that deviated most strongly from HWE. All yielded the same results, except for an SNP in the SORBS1 (rs2274490) and CETP (rs1800775) gene, which were, therefore, excluded from further analysis.
Power calculation
On the basis of the sample size, it was estimated that for a variant with 20% prevalence, there was 480% power to detect a 0.5-kg/m 2 difference in BMI and a 1.4-cm difference in waist between genotypes. For a variant with 5%
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Statistical analyses
Four SNPs were excluded because their MAF was below 0.02 (rs1805348, rs11569620, rs17634758, rs5352), resulting in too few heterozygous subjects to do a meaningful analyses. Another 22 SNPs were excluded because they were highly correlated (r 2 40.8) with another SNP in the dataset (see Supplementary table) . As highly correlated SNPs will show similar associations with BMI or waist, including both SNPs in the dataset will result in an unnecessary more stringent adjustment for multiple testing. Finally, data on 327 SNPs in 239 genes were available for statistical analysis.
Distributions of genotypes were tested for deviation from HWE by w 2 analysis (PROC ALLELE; SAS version 9.1; SAS Institute, Inc, Cary, NC, USA).
As BMI distribution showed a positive skew, BMI values were log-transformed before analyses. BMI and waist circumference values at the second and third measurements were available for nearly all participants (499.5%). There were no missing BMI values at the first measurement.
For this study, we used repeated measurement of BMI and waist circumference to estimate a mean level of BMI or waist. To account for correlation between repeated measures within subjects, random coefficient models (multi-level modeling) were used to study the relationship between SNPs and repeated measurements of BMI and waist (PROC MIXED). For each SNP, we assumed a similar change in BMI or waist over time between the genotypes. A total of 14 SNPs deviated from this assumption for BMI and 22 SNPs for waist and were, therefore, excluded from BMI or waist analysis. As random coefficient models allow for missing outcome data as long as any omission can be assumed to be completely random, all 3575 participants were included in the analysis. 33 Model composition started with a model comprising BMI or waist, a random intercept and time of each measurement entered as exact follow-up time in years with the first measurement coded as zero. Second, a random slope was added to the model and the model fit was evaluated by the likelihood ratio test. Third, non-linear development of BMI over time was considered by adding quadratic and cubic follow-up time to the model and model fit was evaluated. Fourth, predictor variables as age and gender were added to the model as fixed effect and statistical significance was evaluated. Fifth, model improvements were considered by adding potential interactions terms between significant predictor variables. Finally, the basic model for BMI included sex, age, age-by-time and age-by-sex interaction as fixed effects and intercept and time as random effects. Compared with the BMI model, two modifications were made with respect to the basic model for waist circumference. First, the interaction between time and sex was statistically significant and, therefore, included in the waist model. Second, the variable time defined as a random effect was not statistically significant and, therefore, time was added as a fixed effect.
Differences in BMI and waist circumference level between genotypes were analyzed by adding the SNPs by turns to the basic models. Associations with BMI or waist level below P-value 0.05 were tested for interaction between the relevant SNPs and gender. In case of a significant interaction, the results are presented for men and women separately. All analyses regarding SNPs located on the X chromosome (n ¼ 5) were performed for men and women separately.
The false discovery rate, which is a commonly accepted method in high-througput genomic studies, was applied to take into account the multiple tests performed. 34, 35 False discovery rate q-values were calculated by multiplying the P-values by the number of tests performed and then dividing them by the rank order of each P-value. Rank order 1 was assigned to the smallest P-value. To ensure that the q-values have the same ordering as the P-values, q-values were defined as the minimum of q-values observed for that P-value or higher P-values. However, there is no conventional q-value threshold to evaluate statistical significance. Therefore, similar to other publications, a q-value threshold of 0.20 was applied to indicate those SNPs with most significant associations.
36,37
The Fisher's exact test was used to evaluate the frequency of TFBS-related SNPs among the SNPs associated with overweight.
Results
The study population consisted of slightly more women than men (Table 1) . Approximately, 25% of the participants Candidate gene pathways and obesity SW van den Berg et al were current smokers and about 40% were non-smokers. At the start of the study, the median age was 41 years, about 40% of the participants were overweight and approximately 6% were obese. Between the first and third measurements, the prevalence of overweight increased one and a half times, whereas the prevalence of obesity more than doubled. A total of 31.3% of the participants had abdominal obesity at the second measurement, which increased to 40.2% at the last measurement. Two intronic SNPs were significantly associated (qp0.20) with BMI as well as with waist circumference (waist). Subjects with the AA or AG genotype for rs10860603 in the NR1H4 gene had a significant lower BMI (0.8 and 0.4 kg/m 2 , respectively) and waist (2.3 and 1.1 cm, respectively) than subjects with the GG genotype (Figures 1a and b) . The other SNP, located in the SMARCA2 gene (rs17712152), showed a statistically significant interaction with gender for both BMI (P ¼ 0.006) and waist (P ¼ 0.005). Women with the GG genotype had a 0.7-kg/m 2 higher BMI and a borderline significant higher waist (1.5 cm; P ¼ 0.09) than women with the GA genotype. Women with the AA genotype had the highest BMI and waist; however, this group was very small (n ¼ 4). For men, no associations were observed. Two other polymorphisms, that is in the SCAP and SIRT1 gene, were significantly related to BMI only with q-values below 0.20. For the SCAP intron 3 AT polymorphism (rs6800271), an interaction with gender was observed (P ¼ 0.005). Women with the AT genotype had a 0.7-kg/m 2 higher BMI compared with women with AA genotype. For men, no difference in BMI between the SCAP genotypes was found. Subjects heterozygous for the SIRT1 1047 TC polymorphism (rs2273773) had a 0.5-kg/m 2 higher BMI than TT subjects. Finally, a significant association (q ¼ 0.03) with waist was observed for the IL6 -573 GC polymorphism (rs1800796). Subjects with the CC genotype had a 7.6-and 8.7-cm lower waist than, respectively, GC and GG subjects ( Figure 2 Table 2 ). An overview of the associations with BMI and waist for each SNP separately is briefly reported in Supplementary Table 3 . Twenty-two SNPs highly correlating (r 2 40.80) with another SNP were excluded to achieve a less stringent multiple Candidate gene pathways and obesity SW van den Berg et al rs1800796 (IL6), the significant associated SNPs (qp0.20) are all among the transcription mediators (Tables 2 and 3) . When selecting SNPs using SNPselector, preference was given to SNPs located in predicted TFBS (see Materials and methods). Remarkably, all TFBS-associated SNPs with a q-value p0.20 (3 for BMI and 2 for waist; Tables 2 and 3) had conserved GATA motifs, whereas only 19 (17%) SNPs of all 110 successfully genotyped TFBS-associated SNPs had GATA motifs. Fisher's exact test indicates that this is a significant enrichment of GATA motifs among TFBS-associated SNPs for BMI (P ¼ 0.0045) and waist (P ¼ 0.029). The GATA motifs remained significantly enriched when extended to all TFBSassociated SNPs with a P-value below 0.05: 5 out of 12 for BMI (P ¼ 0.033) and 3 of 4 for waist (P ¼ 0.016) (Supplementary Tables 1 and 2 ), suggesting a potential role of GATA transcription factors in weight regulation.
Discussion
In this explorative study among 3575 participants of the Doetinchem Cohort, significant associations (qp0.20) were detected between adiposity and five SNPs across genes from regulatory pathways controlling fatty acid and glucose metabolism (NR1H4, SMARCA2, SIRT1, SCAP, IL6).
Strengths of this pathway-driven candidate gene study were the relatively large sample size and the availability of repeated obesity-phenotype measurements, which improve study power and precision. Another strength was that we calculated false discovery rate q-values to reduce the chance of false positive findings. As there is no conventional threshold, an arbitrary cutoff point of 0.20 was used, as in similar research. 36, 37 A more stringent threshold is often used in genome-wide association studies, which do not use prior information to select candidate genes. As an enrichment for genes in pathways influencing the studied phenotypes based on molecular studies prospects a higher frequency of true associated variations, a cutoff point of 0.20 seems to be justified. This study has limitations regarding the replication of the associations, functionalities of the associated SNPs and the underlying mechanism by which the SNPs may contribute to the phenotype of interest. Below, these aspects will be discussed for the significant (qp0.20) individual associations. There is in vitro evidence that the IL6 -573 variant (rs1800796) is a functional polymorphism. The -573C allele has been associated with higher IL6 gene expression levels. 38 In this study, we found a lower waist among subjects with the IL6 -573 CC genotype. How higher IL6 gene expression levels may induce a lower waist remains to be elucidated. There is evidence for a regulatory role of IL6 in long-term energy balance by acting as an adiposity signal. 39 In human beings, IL-6 serum levels correlate with adipose tissue to the same extent as leptin. In addition, in the brain, IL6 favors a negative energy balance, as it decreases food intake. We are the first who report a lower waist among IL6 -573 CC carriers. Therefore, replication of this finding is necessary. Our finding seems to be in contrast with a study of Slattery et al. 40 who reported a slightly higher waist-to-hip ratio (0.01) among 1330 non-Hispanic white women carrying the -573 C-allele. However, no separate data for waist circumference were given. Hamid et al. 41 found no association between the IL6 -573 variant and BMI among 7500 Caucasian Danes. They reported a similar allele frequency and genotype distribution to our study and also observed deviation from HWE for this IL6 variant. We verified our genotyping data, which yielded the same results. Therefore, it seems to be unlikely that errors in the genotype measurement can explain the atypical genotype distribution. This study shows that the IL6 -573 polymorphism is strongly associated with waist, also after adjustment for BMI (Po0.0001). Together, this makes IL6 an important candidate gene for abdominal obesity. We also included the most investigated IL6 polymorphism, the -174GC variant (rs1800795). A recent meta-analysis does not support a role for this polymorphism in adiposity, 42 which is in concordance with our study (BMI; P ¼ 0.11 and waist; P ¼ 0.92).
So far, there is no information about the functionality of the associated SNPs in SIRT1, NR1H4, SCAP and SMARCA2. In addition, no genetic association studies have been conducted on these SNP in relation to obesity phenotypes yet. However, there is some supportive evidence from genome-wide association studies for a role of these genes in obesity. Furthermore, there is some knowledge about the underlying mechanisms.
In this study, subjects with the SIRT1 rs2273773 TC genotype had a higher BMI than TT subjects. The results from a genome-wide scan show a strong association between a marker in SIRT1 and body weight among Scandinavian subjects with diabetes.
43 SIRT1 acts as a nutrient sensor and is thought to be a molecular switch relaying the beneficial effects of caloric restriction on a healthy phenotype and longevity. 44 Hence, involvement of SIRT1 in human body weight regulation seems likely. In 2006, very strong associations between SNPs located in and near the NR1H4 gene and waist were reported by the genome-wide SNP scan of the Framingham Heart study (P-values 0.006, 0.0007, 0.0008, 0.00003). 45 In our study, for two independent SNPs both located in the NR1H4 gene (r 2 ¼ 0.23; D 0 prime ¼ 0.22), associations with BMI as well as waist were observed (rs10860603, rs35724; see Supplementary Tables 1 and 2 ). Our results in combination with those from the Framingham Heart study designate the NR1H4 gene as a very interesting candidate gene for obesity. As bile acids were shown to increase the metabolic rate in mice, it can be speculated that FXR (NR1H4), which is activated by bile acids, may influence body weight through an effect on energy expenditure. 46 This study showed a very high BMI and waist in the four women with the SMARCA2 intron 9 AA genotype. All of them were overweight and three were obese. However, because of the small numbers, the results for this group Candidate gene pathways and obesity SW van den Berg et al should be interpreted with caution. Our results are supported by the findings from a genome-wide association study among Scandinavian subjects with diabetes, which showed a strong association between a marker near to the SMARCA2 gene and body weight and waist circumference. 43 SREBF chaperone (SCAP) is the sterol sensing receptor directly interacting with and controlling SREBP transcription factor activation. 47 The few genetic association studies on this gene mainly focused on the SCAP Ile796Val variant (not included in our study). No associations were found between the Ile796Val variant and interindividual variation in druginduced weight gain 48 and metabolic changes during weight gain. 49 In this study, the association between SCAP intron 3 AT polymorphism and BMI was only observed among women. The mechanism that can explain this gender difference is unknown. However, a change finding cannot be excluded either. In summary, for all significantly associated SNPs (qp0.20) replication of the reported association is necessary. In addition, we tried to select those SNPs most likely to be functional, but we have no certainty about the functionality, except for the IL6 -573 variant (rs1800796). Therefore, more research is needed to investigate the functionality of the SNPs. Furthermore, only a small part of the genetic variation for each gene was taken into account in this study. Hence, we cannot exclude the possibility that genes for which we found no association are in fact associated with obesity phenotypes.
A specific aim of this study was to highlight, by association, (sub)pathways in which interindividual genetic variation leads to differences in body weight. As the majority of the significant associated SNPs (qp0.20) are located in transcription mediator genes (Tables 2 and 3 ), the potential involvement of this subpathway was further explored. Below, known protein-protein interactions for the transcription mediators genes (Po0.05) are briefly described (Supplementary Tables 1 and 2 ). Nuclear receptors such as the farnesoid X receptor (NR1H4) and the thyroid hormone receptor heterodimerize with retinoid X receptors (RXR), of which RXRG is one of three family members, to bind to DNA response elements. 50 Depending on ligand availability, the nuclear receptor heterodimer associates with repressors or co-activators, 51 ) and by bridging histone acetylation activity with the transcription mediator complex (TGS1 55 ). The latter, that is bridging of histone acetylation and transcription mediation, is combined with tissue specificity in PPAR gamma co-activators, with PPARGC1B as one of the three family members. 56 Gluconeogenic gene expression in liver driven by the best-studied PPAR gamma co-activator family member, PPAR gamma co-activator-1a, is enhanced after deacetylation by sirtuin 1 (SIRT1), a sensor for nutritional status. 44 In a recent publication, KLF5 was identified as a ligand dependant mediator of PPAR repressor activity, by attracting NCOR1 and 2 and co-activation activity through (de)SUMOylation, regulating lipid metabolism in muscle and adipocyte differentiation. 57 Hence, it is tempting to speculate that genetic variations in interacting transcription mediators influence body weight phenotypes through differential expression of nuclear receptor target genes. Furthermore, a large fraction of the SNPs that were associated with BMI or waist (Po0.05), and in particular among the subclass of transcription mediators, are associated with conserved TBFS as identified by SNPselector (Supplementary Tables 1 and 2 ). Given the study design of selecting transcription factors and their targets, one might have expected most TFBS-SNPs to be present among the effectors. However, the TFBS-SNPs were not selected based on any specific transcription factor motifs, but simply ranked by Function_score and Regulatory_score as described in the Materials and methods section, resulting in only five genotyped SNPs associated with conserved motives for transcription factors and co-regulators that formed the basis of this study. None of these five SNPs reached significance levels. Instead, a combination of GATA motifs was found to be significantly enriched, suggesting a role of GATA transcription factors in weight regulation, by controlling the transcription mediators themselves. Indeed, at least two members of the GATA family, GATA2 and 3, have been functionally implicated as gate keepers at the onset of adiposite differentiation, requiring GATA expression to be down-regulated. 58 In conclusion, in our explorative study among 3575 participants of a large population-based cohort, we detected five SNPs strongly associated with obesity phenotypes. Findings from genome-wide association or candidate gene studies support the potential role of the NR1H4, SIRT1, SMARCA2 and IL6 gene in obesity. Although, replication of these findings in independent study populations is needed and further research on the functionality of most of these SNPs is necessary, our data indirectly suggests a role of GATA transcription factors in weight regulation.
